Home News Knowledges Pharmaceutical Wastewater with COD above 6000 mg/L: Inside a CDOF Catalytic Ozonation Train

Pharmaceutical Wastewater with COD above 6000 mg/L: Inside a CDOF Catalytic Ozonation Train

2026-11-16 5 readings

Pharmaceutical industrial wastewater is rich in refractory organic matter, heavy metals and biotoxic substances, posing a serious threat to aquatic ecosystems and human health. The concentrations leave little margin: at one large pharmaceutical manufacturer, for example, the wastewater COD exceeded 6000 mg/L, far above the national standard. Catalytic ozonation answers with strong oxidising power, decomposing refractory organics in the presence of a catalyst and markedly reducing COD, BOD and other indicators, which makes it a green and efficient deep purification route for this stream.

Core Process: How CDOF Combines Three Mechanisms

The cyclonic dissolved air flotation unit known as CDOF combines advanced oxidation with ozone, cyclonic intensified mixing and dissolved air flotation, achieving efficient coordinated removal of pollutants. Its core lies in three mechanisms working together.

  • Multiple catalytic oxidation: homogeneous catalysis with metal ions combined with heterogeneous catalysis on a porous carrier markedly lowers the activation energy, accelerating ozone decomposition into highly reactive hydroxyl radicals and improving oxidation efficiency.
  • Cyclonic intensified mass transfer: the cyclonic action greatly improves the mixing of ozone with the wastewater.
  • Green flotation enhancement: the de-gelling and demulsifying properties of ozone reduce flocculant dosage and improve effluent quality.

CDOF operates fully automatically under pressure in a closed vessel: ozone dissolves and disperses rapidly, giving a high reaction rate and short contact time. Ozone utilisation exceeds 99%, the footprint is only 1/3 of that of conventional processes, and there is no risk of ozone leakage or harmful by-products, in line with green, low-carbon and sustainable development.

The Proprietary Heterogeneous Ozone Catalyst

The unit is packed with an in-house developed high-efficiency ozone catalyst whose design carries four advantages:

  • Nanoscale active components: noble-metal and transition-metal composites with a particle size controlled below 10 nm, greatly increasing specific surface area and reaction efficiency.
  • Deep oxidation capability: efficient decomposition of organic matter even at low ozone concentration.
  • Outstanding stability: a unique surface structure and anti-poisoning mechanism resist impurities in the wastewater, with a low activity loss rate, below 5% after several months of industrial operation.
  • Long service life and economy: a service life of several years, far above the industry average.

Strict testing has confirmed that in pharmaceutical wastewater treatment the SINOKLE series ozone catalyst achieves a stable COD removal of more than 80% and a colour removal of nearly 100%.

Operating the Train Day to Day

Plant practice around a CDOF unit concentrates on three habits. Ozone dose is the primary control handle, and it should track the incoming COD rather than run at a fixed setpoint, because the economics above depend on the oxidant going into the organics rather than into the background matrix. Catalyst condition is the second: activity loss stays below 5% over months of industrial operation, but periodic sampling of effluent COD at constant ozone dose is the cheapest way to spot any drift early. The third habit concerns the flotation stage, whose demulsifying benefit is easy to take for granted; flocculant savings only persist if operators resist the reflex to dose polymer when the raw water turns dark, since the ozone itself is doing that de-gelling work. Plants that hold those three disciplines report the short 45-minute retention times and the near-total colour removal as routine results rather than best-case ones. None of this requires exotic instrumentation; an online COD analyser at the outlet and a routine ozone audit of the closed vessel are enough to keep the whole loop honest.

Field Results from Inner Mongolia

At a large pharmaceutical plant in Inner Mongolia the wastewater COD reaches several thousand mg/L, and conventional biological treatment is inefficient, achieving a COD removal of only about 15%. After adopting the CDOF process the results were remarkable on every indicator that matters:

  • Efficient treatment: a retention time of only 45 minutes.
  • Outstanding results: the brown, highly toxic raw water becomes clear, transparent effluent; COD falls below 200 mg/L and suspended solids (SS) measure 20 mg/L or less.
  • Improved biodegradability: the B/C ratio rises from below 0.1 to 0.37, favouring subsequent biological treatment.
  • Stable and economical operation: the long life and low attrition of the catalyst ensure efficient long-term operation.

Why the Combination Works for This Stream

Pharmaceutical effluent punishes single-mechanism approaches. Biology stalls on biotoxic substances; plain ozone dosing wastes reagent on side reactions; standalone flotation cannot touch dissolved refractory organics. The CDOF arrangement stacks the mechanisms so each covers the others' blind spots: cyclonic mixing drives ozone into contact, the catalyst converts ozone into hydroxyl radicals that attack refractory molecules, and flotation carries out the particulate load that would otherwise shield organics from oxidation.

The catalytic ozonation process with its efficient, green and compact characteristics successfully solves the difficult problem of advanced pharmaceutical wastewater treatment, setting a technical benchmark for the industry and leading pharmaceutical wastewater treatment into a new stage of resource conservation and environmental friendliness.